IFNA2 and COVID-19: Although several sera from COVID-19 convalescent plasma donors had ELISA-detectable IFN-α2 Abs, they did not neutralize the same levels of IFN-α2 compared to acute COVID-19 patients and their plasma had not been used for convalescent plasma treatment.